L-arginine and hypertension

Journal of Nutrition

Volumn 134, Issue 10 SUPPL., 2004, Pages

  Gokce, Noyan ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Endothelium; Hypertension; L arginine; Nitric oxide

Indexed keywords

ANGIOTENSIN; ARGININE; CITRULLINE; ENDOTHELIN 1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TRIACYLGLYCEROL;

AGING; BLOOD VESSEL TONE; CONFERENCE PAPER; CORONARY ARTERY BLOOD FLOW; DIET SUPPLEMENTATION; HUMAN; HYPERTENSION; INSULIN SENSITIVITY; KIDNEY BLOOD FLOW; METABOLIC SYNDROME X; NONHUMAN; OBESITY; OXIDATIVE STRESS; VASCULAR ENDOTHELIUM;

EID: 4744362273     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/134.10.2807s     Document Type: Conference Paper

References (55)

1. Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L., Jr., Jones, D. W., Materson, B. J., Oparil, S. et al. (2003) The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. J. Am. Med. Assoc. 289: 2560-2572.
2. Vasan, R. S., Beiser, A., Seshadri, S., Larson, M. G., Kannel, W. B., D'Agostino, R. B. & Levy, D. (2002) Residual lifetime risk for developing hypertension in middle-aged women and men: the Framingham Heart Study. J. Am. Med. Assoc. 287: 1003-1010.
3. Haffner, S. & Taegtmeyer, H. (2003) Epidemic obesity and the metabolic syndrome. Circulation 108: 1541-1545.
4. Dominiczak, A. F. & Bohr, D. F. (1995) Nitric oxide and its putative role in hypertension. Hypertension 25: 1202-1211.
5. Huang, P. L., Huang, Z., Mashimo, H., Bloch, K. D., Moskowitz, M. A. & Bevan, J. A. (1995) Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377: 239-242.
6. Baylis, C., Mitruka, B. & Deng, A. (1992) Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J. Clin. Invest. 90: 278-281.
7. Brush, J. E., Faxon, D. P., Salmon, S., Jacobs, A. K. & Ryan, T. J. (1992) Abnormal endothelium-dependent coronary vasomotion in hypertensive patients. J. Am. Coll. Cardiol. 19: 809-815.
8. Panza, J. A., Quyyumi, A. A., Brush, J. E. & Epstein, S. E. (1990) Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N. Engl. J. Med. 323: 22-27.
9. Cockcroft, J. R., Chowienczyk, P. J., Benjamin, N. & Ritter, J. M. (1994) Preserved endothelium-dependent vasodilation in patients with essential hypertension. N. Engl. J. Med. 330: 1036-1040.
10. G-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears normal. J. Hypertens. 10: 1025-1031.
11. Gokce, N., Holbrook, M., Duffy, S. J., Demissie, S., Cupples, L. A., Biegelsen, E., Keaney, J. F., Jr., Loscalzo, J. & Vita, J. A. (2001) Effects of race and hypertension on flow-mediated and nitroglycerin-mediated dilation of the brachial artery. Hypertension 38: 1349-1354.
12. Gokce, N., Keaney, J. F., Jr. & Vita, J. A. (1998) Endotheliopathies: clinical manifestations of endothelial dysfunction. In: Thrombosis and Hemorrhage (Loscalzo, J. & Shafer, A. I., eds.), pp. 901-924. Williams and Wilkins, Baltimore, MD.
13. Chen, P. Y. & Sanders, P. W. (1991) L-Arginine abrogates salt-sensitive hypertension in Dahl/Rapp Rats. J. Clin. Invest. 88: 1559-1567.
14. Shultz, P. J. & Tolins, J. P. (1993) Adaptation to increased dietary salt intake in the rat: role of endogenous nitric oxide. J. Clin. Invest. 91: 642-650.
15. Arnal, J. F., Warin, L. & Michel, J. B. (1992) Determinants of aortic cyclic guanosine monophosphate in hypertension induced by chronic inhibition of nitric oxide synthase. J. Clin. Invest. 90: 647-652.
16. Shesely, E. G., Maeda, N., Kim, H. S., Desai, K. M., Krege, J. H., Laubach, V. E., Sherman, P. A., Sessa, W. C. & Smithies, O. (1996) Elevated blood pressure in mice lacking endothelial nitric oxide synthase. Proc. Natl. Acad. Sci. U.S.A. 93: 13176-13181.
17. Taddei, S., Virdis, A., Mattei, P., Chiadoni, L., Sudano, I. & Salvetti, A. (1996) Defective L-arginine-nitric oxide pathway in offspring of essential hypertensive patients. Circulation 94: 1298-1303.
18. Luscher, T. F., Vanhoutte, P. M. & Raij, L. (1987) Antihypertensive treatment normalizes decreased endothelium-dependent relaxations in rats with salt-induced hypertension. Hypertension 9: III193-III197.
19. Perticone, F., Ceravolo, R., Pujia, A., Ventura, G., Iacopino, S., Scozzafava, A., Ferraro, A., Chello, M., Mastroroberto, P. et al. (2001) Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation 104: 191-196.
20. Modena, M. G., Bonetti, L., Coppi, F., Bursi, F. & Rossi, R. (2002) Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women. J. Am. Coll. Cardiol 40: 505-510.
21. Quyyumi, A. A., Dakak, N., Diodati, J. G., Gilligan, D. M., Panza, J. A. & Cannon, R. O. (1997) Effect of L-arginine on human coronary endothelium-dependent and physiologic vasodilation. J. Am. Coll. Cardiol. 30: 1220-1227.
22. Lerman, A., Burnett, J. C. J., Higano, S. T., McKinley, L. J. & Holmes, D. R. J. (1998) Long-term L-arginine supplementation improves small-vessel coronary endothelial function in humans. Circulation 97: 2123-2128.
23. Panza, J. A., Casino, P. R., Badar, D. M. & Quyyumi, A. A. (1993) Effect of increased availability of endothelium-derived nitric oxide precursor on endothelium-dependent vascular relaxation in normal subjects and in patients with essential hypertension. Circulation 87: 1475-1481.
24. Lekakis, J. P., Papathanassiou, S., Papaioannou, T. G., Papamichael, C. M., Zakopoulos, N., Kotsis, V., Dagre, A. G., Stamatelopoulos, K., Protogerou, A. & Stamatelopoulos, S. F. (2002) Oral L-arginine improves endothelial dysfunction in patients with essential hypertension. Int. J. Cardiol. 86: 317-323.
25. Pagnotta, P., Germano, G., Grutter, G., Leonardo, F., Rosano, G. & Chierchia, S. (1997) Oral L-arginine supplementation improves essential arterial hypertension. Circulation 96 (suppl. 8S): 538-1.
26. Higashi, Y., Oshima, T., Ozono, R., Watanabe, M., Matsuura, H. & Kajiyama, G. (1995) Effects of L-arginine infusion on renal hemodynamics in patients with mild essential hypertension. Hypertension 25: 898-902.
27. Piatti, P., Fragasso, G., Monti, L. D., Setola, E., Lucotti, P., Fermo, I., Paroni, R., Galluccio, E., Pozza, G. et al. (2003) Acute intravenous L-arginine infusion decreases endothelin-1 levels and improves endothelial function in patients with angina pectoris and normal coronary arteriograms: correlation with asymmetric dimethylarginine levels. Circulation 107: 429-436.
28. Higashi, Y., Oshima, T., Ono, N., Hiraga, H., Yoshimura, M., Watanabe, M., Matsuura, H., Kambe, M. & Kajiyama, G. (1995) Intravenous administration of L-arginine inhibits angiotensin-converting enzyme in humans. J. Clin. Endocrinol. Metab. 80: 2198-2202.
29. Sato, K., Kinoshita, M., Kojima, M., Miyagawa, K., Takase, H., Suzuki, S. & Dohi, Y. (2000) Failure of L-arginine to induce hypotension in patients with a history of accelerated-malignant hypertension. J. Hum. Hypertens. 14: 485-488.
30. Bode-Boger, S. M., Boger, R. H., Galland, A., Tsikas, D. & Frolich, J. C. (1998) L-Arginine-induced vasodilation in healthy humans: pharmacokinetic-pharmacodynamic relationship. Br. J. Clin. Pharmacol. 46: 489-497.
31. Mehta, S., Stewart, D. J., & Levy, R. D. (1996) The hypotensive effect of L-arginine is associated with increased expired nitric oxide in humans. Chest 109: 1550-1555.
32. Nelin, L. D. & Hoffman, G. M. (2001) L-Arginine infusion lowers blood pressure in children. J. Pediatr. 139: 747-749.
33. Matsuoka, H., Nakata, M., Kohno, K., Koga, Y., Nomura, G., Toshima, H. & Imaizumi, T. (1996) Chronic L-arginine administration attenuates cardiac hypertrophy in spontaneously hypertensive rats. Hypertension 27: 14-18.
34. Campese, V. M., Amar, M., Anjali, C., Medhat, T. & Wurgaft, A. (1997) Effect of L-arginine on systemic and renal haemodynamics in salt-sensitive patients with essential hypertension. J. Hum. Hyper. 11: 527-532.
35. Loscalzo, J. (2000) What we know and don't know about L-arginine and NO. Circulation 101: 2126-2129.
36. Venho, B., Voutilainen, S., Valkonen, V. P., Virtanen, J., Lakka, T. A., Rissanen, T. H., Ovaskainen, M. L., Laitinen, M. & Salonen, J. T. (2002) Arginine intake, blood pressure, and the incidence of acute coronary events in men: the Kuopio Ischaemic Heart Disease Risk Factor Study. Am. J. Clin. Nutr. 76: 359-364.
37. Kamada, Y., Nagaretani, H., Tamura, S., Ohama, T., Maruyama, T., Hiraoka, H., Yamashita, S., Yamada, A., Kiso, S. et al. (2001) Vascular endothelial dysfunction resulting from L-arginine deficiency in a patient with lysinuric protein intolerance. J. Clin. Invest. 108: 717-724.
38. Vallance, P., Leone, A., Calver, A., Collier, J. & Moncada, S. (1992) Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 339: 572-575.
39. Boger, R. H., Bode-Boger, S. M., Szuba, A., Tsao, P. S., Chan, J. R., Tangphao, O., Blaschke, T. F. & Cooke, J. P. (1998) Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation 98: 1842-1847.
40. Cooke, J. P. (2000) Does ADMA cause endothelial dysfunction? Arterioscler. Thromb. Vasc. Biol. 20: 2032-2037.
41. Matsuoka, H., Itoh, S., Kimoto, M., Kohno, K., Tamai, O., Wada, Y., Yasukawa, H., Iwami, G., Okuda, S. & Imaizumi, T. (1997) Asymmetrical dimethylarginine, an endogenous nitric oxide synthase inhibitor, in experimental hypertension. Hypertension 29: 242-247.
42. Kielstein, J. T., Impraim, B., Simmel, S., Bode-Boger, S. M., Tsikas, D., Frolich, J. C., Hoeper, M. M., Haller, H. & Fliser, D. (2004) Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans. Circulation 109: 172-177.
43. Scherrer, U., Randin, D., Vollenweider, P., Vollenweider, L. & Nicod, P. (1994) Nitric oxide release accounts for insulin's vascular effects in humans. J. Clin. Invest. 94: 2511-2515.
44. Steinberg, H. O., Brechtel, G., Johnson, A., Fineberg, N. & Baron, A. D. (1994) Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J. Clin. Invest. 94: 1172-1179.
45. Ferrannini, E., Buzzigoli, G., Bonadonna, R., Giorico, M. A., Oleggini, M., Graziadei, L., Pedrinelli, R., Brandi, L. & Bevilacqua, S. (1987) Insulin resistance in essential hypertension. N. Engl. J. Med. 317: 350-357.
46. Grundy, S. M., Brewer, H. B., Jr., Cleeman, J. I., Smith, S. C., Jr. & Lenfant, C. (2004) Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109: 433-438.
47. Flegal, K. M., Carroll, M. D., Ogden, C. L. & Johnson, C. L. (2002) Prevalence and trends in obesity among US adults, 1999-2000. J. Am. Med. Assoc. 288: 1723-1727.
48. Giugliano, D., Marfella, R., Verrazzo, G., Acampora, R., Coppola, L., Cozzolino, D. & D'Onofrio, F. (1997) The vascular effects of L-arginine in humans: The role of endogenous insulin. J. Clin. Invest. 99: 433-438.
49. Giugliano, D., Marfella, R., Coppola, L., Verrazzo, G., Acampora, R., Giunta, R., Nappo, F., Lucarelli, C. & D'Onofrio, F. (1997) Vascular effects of acute hyperglycemia in humans are reversed by L-arginine: evidence for reduced availability of nitric oxide during hyperglycemia. Circulation 95: 1783-1790.
50. Siani, A., Pagano, E., Iacone, R., Iacoviello, L., Scopacasa, F. & Strazzullo, P. (2000) Blood pressure and metabolic changes during dietary L-arginine supplementation in humans. Am. J. Hypertens. 13: 547-551.
51. Piatti, P. M., Monti, L. D., Valsecchi, G., Magni, F., Setola, E., Marchesi, F., Galli-Kienle, M., Pozza, G. & Alberti, K. G. (2001) Long-term oral L-arginine administration improves peripheral and hepatic insulin sensitivity in type 2 diabetic patients. Diabetes Care 24: 875-880.
52. Wascher, T. C., Graier, W. F., Dittrich, P., Hussain, M. A., Bahadori, B., Wallner, S. & Toplak, H. (1997) Effects of low-dose L-arginine on insulin-mediated vasodilation and insulin sensitivity. Eur. J. Clin. Invest 27: 690-695.
53. Marfella, R., Acampora, R., Verrazzo, G., Ziccardi, P., De Rosa, N., Giunta, R. & Giugliano, D. (1996) Metformin improves hemodynamic and rheological responses to L-arginine in NIDDM patients. Diabetes Care 19: 934-939.
54. Asagami, T., Abbasi, F., Stuelinger, M., Lamendola, C., McLaughlin, T., Cooke, J. P., Reaven, G. M. & Tsao, P. S. (2002) Metformin treatment lowers asymmetric dimethylarginine concentrations in patients with type 2 diabetes. Metabolism 51: 843-846.
55. Ziccardi, P., Nappo, F., Giugliano, G., Esposito, K., Marfella, R., Cioffi, M., D'Andrea, F., Molinari, A. M. & Giugliano, D. (2002) Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 105: 804-809.